Announcing the launch of ComplianceAuthor for Global Labeling, an industry-leading solution powered by Quark Publishing Platform, Arria, and Docxonomy. As a result of these partnerships, this solution offers process improvement and world-wide synchronization. You can also expect improved label coordination resulting in enhanced patient safety. Also, speed-to-market and reduced costs are also benefits of ComplianceAuthor.

Glemser is known in the life sciences industry for our Labeling solution and continued work with global health authorities. By partnering with Quark, Arria and Docxonomy, we have created a SaaS (Software as a Service) combining the latest advances in machine-learning, artificial intelligence and compliance. Your company save tens of millions of dollars by leveraging our ComplianceAuthor for Global Labeling solution.

Quark’s Publishing Platform allows for compliant content authoring using applied artificial intelligence, the ability to transform content for reuse, and user experience and business improvements. Arria’s Natural Language Generation enhances the patient experience by improving label coordination. Docxonomy is known for their industry-wide search engine, artificial intelligence model and vector verification. Glemser integrates these technologies into a seamless system that solves global labeling problems.

Learn more by contacting Kevin Morgan, Senior VP of Client Success, at


Glemser serves life science clients by ensuring product quality, improving regulatory compliance, and gaining operational efficiencies that reduce costs. We develop industry-leading IT solutions and services that are essential for life science clients throughout North America, Europe, and Asia to solve their most pressing challenges in quality, compliance, and efficiency. Dedication to client success is of the upmost importance to us, as evidenced though our quality and proven methods for over 30 years. Our talented global professionals and approach to quality result in client engagements that are on time, on budget, and on benefit.